NEUMORA THERAPEUTICS, INC.
Profit History
| Fiscal Year | Revenue | Operating Income | Net Income |
|---|---|---|---|
| FY2022 | — | $-135.9M | $-130.9M |
| FY2023 | — | $-252.1M | $-235.9M |
| FY2024 | — | $-263.5M | $-243.8M |
| FY2025 | — | $-241.2M | $-236.9M |
Profit History
| Fiscal Year | Revenue | Operating Income | Net Income |
|---|---|---|---|
| FY2022 | — | $-135.9M | $-130.9M |
| FY2023 | — | $-252.1M | $-235.9M |
| FY2024 | — | $-263.5M | $-243.8M |
| FY2025 | — | $-241.2M | $-236.9M |